Eli Lilly launched an ad campaign on Friday, cautioning patients against the risks of unapproved weight-loss drugs in its ...
Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...
Pharmaceutical giant expects the move will create 3,000 high-skilled jobs and provide work for approximately 10,000 ...
In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...
Eli Lilly is seeking to further cement its stance as a leader in weight loss drugs in an ad campaign calling out “unapproved” medications.
Hugely popular weight loss drugs known as GLP-1's are finally getting cheaper, well at least one is, and that's the case with ...
11h
Verywell Health on MSNEli Lilly Lowers Cost of Zepbound Vials to Attract People Without Insurance CoverageEli Lilly is now offering four doses of Zepbound in self-administration vials. The lower-cost self-pay option targets people ...
Eli Lilly is airing an ad during the Academy Awards urging customers to adopt a health skepticism when marketed drug brands that are not FDA-approved.
Eli Lilly is partnering with Imagine Entertainment and MACRO to drive industry-wide change and guide in authentically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results